Keygene

What Keygene does

KeyGene is a privately held Dutch AgBiotech research company founded in 1989 and headquartered in Wageningen, with additional R&D operations in Rockville, Maryland, and Hyderabad, India. It operates as a B2B contract research and technology innovation partner serving global vegetable, fruit, ornamental, and industrial crop breeders, as well as licensing customers in healthcare, diagnostics, and biotechnology services. The company is wholly owned by four strategic shareholders — Enza Zaden, Rijk Zwaan, Limagrain Vegetable Seeds (Vilmorin & Cie), and Takii — which simultaneously fund its research programs and act as long-term R&D collaborators.

The company monetizes through three primary streams: (1) technology licensing of its proprietary IP portfolio, including KeyPoint (multiplex genetic-variation detection), 2S1 graft hybrid technology, the PAR gene for apomixis, hormone-free plant regeneration, AFLP, SNPWave, KeySeeQ, CropPedia, ProgressiveSTL, and the PhenoGene breeding optimizer; (2) contract research projects executed for partners; and (3) multi-year strategic R&D collaborations where KeyGene functions as an embedded extension of partner R&D teams. Pricing is bespoke and not publicly disclosed.

KeyGene's technology stack combines DNA/RNA technologies, metabolomics and proteomics, data science and AI, cell and tissue technologies, and trait technologies. Recent platform investments include spatial transcriptomics (Vizgen Merscope), single-nuclei RNA sequencing (10x Genomics Chromium X with Oxford Nanopore long-read integration), an AI-augmented Systems Biology platform for causal trait discovery, automated ultra-high-throughput exome workflows with Twist Bioscience and Beckman Coulter, and T2T genome assembly using Oxford Nanopore duplex sequencing at Q50 accuracy. The technology portfolio is protected by an extensive granted and pending patent estate and was recognized with a #40 ranking in the Netherlands' 2025 R&D Top 50.

Name

Keygene

Legal name

Keygene N.V.

Website

https://keygene.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

51–100 employees

Short description

KeyGene is a private Dutch AgBiotech research company, founded in 1989 and owned by four global seed-breeding shareholders, that develops and licenses proprietary genomics, cell-and-tissue, and AI-enabled crop-improvement technologies for vegetable, fruit, ornamental, and industrial crop breeders worldwide.

Ownership category

akta.pro rank

Product category

Agricultural Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

akta.pro primary industry

Biotechnology & Gene-Edited Trait Development (AFAGAIAG)

akta.pro secondary industries

Gene Editing Trait Development (CRISPR/TALEN/ZFN) (AFABALAB), Trait Discovery & Functional Genomics (Target ID/Validation) (AFABALAC), Transformation & Tissue Culture Platforms (Plant regeneration, delivery systems) (AFABALAH)

Keywords

• Crop improvement research
• Plant breeding technology
• Agricultural genomics services
• Crop biotech licensing
• Plant DNA sequencing

Headquarters

HQ city

Wageningen

HQ country

Netherlands

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Technology Licensing: Licensing of KeyGene's intellectual property including genomics, bioinformatics, cell & tissue culture technologies, and trait technologies to healthcare, biotechnology services, and agro-food sector companies. Favorable conditions apply for not-for-profit research organizations.
2. Contract Research: Research projects conducted for partners using KeyGene's expertise and state-of-the-art technologies to solve specific research questions and service needs according to highest quality standards.
3. Strategic R&D Collaborations: Long-term multi-year collaborative R&D partnerships where KeyGene works closely as integrated R&D team with partners to reach final objectives, combining strengths of all parties.
4. Shareholder Funding: Research largely funded by four international vegetable crop breeding companies (Enza Zaden, Rijk Zwaan, Limagrain Vegetable Seeds, Takii) which are shareholders of KeyGene.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

KeyGene is an agricultural biotechnology research company that develops and applies proprietary technology innovations for crop improvement. Its core offerings combine DNA/RNA technology, metabolomics & proteomics, data science/AI, cell & tissue technology, and trait technologies to accelerate plant breeding for vegetables, fruits, ornamentals, and industrial field crops. The company delivers these capabilities to partners through contract research projects, multi-year strategic R&D collaborations, and technology licensing arrangements.

Product overview

KeyGene operates as a research company providing technology innovation for crop improvement, offering a portfolio of proprietary technologies across genomics, data science, and plant biology. The core offerings include DNA/RNA technologies (sequencing, genotyping, genome editing), data science tools (CropPedia, ProgressiveSTL, PhenoGene), cell and tissue technologies (2S1 graft hybrids, hormone-free regeneration), and trait technologies. These are applied for and with partners including vegetable breeders, fruits, ornamentals, and industrial field crops. KeyGene licenses innovations and provides contract research services to healthcare, biotechnology, and agro-food sectors worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Research Services
• Strategic R&D Collaborations
• Technology Licensing Program
• KeyPoint Breeding Technology
• CropPedia
• ProgressiveSTL
• PhenoGene Breeding Optimizer
• Telomere-to-Telomere Genome Sequencing
• Single-nuclei RNA Sequencing (snRNA-seq)
• Spatial Transcriptomics (Merscope)
• HortControl
• 2S1 Graft Hybrid Technology
• Apomixis Technology
• Hormone-free Plant Regeneration Method
• Single Pollen Nuclei Sequencing
• Automated High-Throughput Plant Exome Workflow

Quantifiable outcome

• First skin-transplant potato variety received plant breeders' rights in Netherlands (March 2025)
• +4 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability8 records

Feature11 records

Partnerships

24 partnerships are on record, tiered major and core.

• 10x GenomicsmajorTechnology or Integration · 1 January 2026KeyGene developed single-nuclei transcriptomics technology based on Chromium X platform from 10x Genomics for analyzing gene expression profiles at single-cell resolution in plants.
• Oxford Nanopore TechnologiesmajorTechnology or Integration · 1 January 2026Applied long-read sequencing technologies alongside short-read sequencing for snRNA-seq libraries, providing additional information on transcript isoforms and their cell-type-specific functional relevance.
• Ultima GenomicsmajorTechnology or Integration · 1 January 2025Joint research on single-pollen nuclei sequencing combining KeyGene's protocols with Ultima Genomics UG 100 platform for better understanding of meiotic recombination in plant breeding.
• Twist BiosciencemajorTechnology or Integration · 1 January 2025Collaboration on ultra-high throughput workflow for plant exome analysis. Twist Bioscience produced custom lettuce exome capturing probe set for the automated workflow.
• Beckman Coulter Life SciencesmajorTechnology or Integration · 1 January 2025Collaboration on automated high-throughput workflow for plant exome analysis. Provided Biomek i7 Dual hybrid workstation with integrated Echo acoustic liquid handler for automated sample processing.
• VizgenmajorTechnology or Integration · 1 January 2025KeyGene acquired Vizgen's Merscope platform for spatial transcriptomics, being first organization in Netherlands to deploy this technology for studying plant-pathogen interactions and plant development.
• Heinrich Heine University Düsseldorf (HHU)majorStrategic or Co-development Partner · 1 January 2025Awarded Marcel van Verk (KeyGene) honorary guest professorship. Partnership with CEPLAS (Cluster of Excellence on Plant Sciences) for scientific exchange and collaborative research. Collaboration also on spatial transcriptomics research.
• CEPLAS (Cluster of Excellence on Plant Sciences)majorStrategic or Co-development Partner · 1 January 2025Partnership for scientific exchange and collaborative research. CEPLAS member Guido Grossmann initiated the guest professorship for KeyGene's Marcel van Verk. KeyGene co-organizes CropIB with CEPLAS.
• VIBmajorGTM or Marketing Partner · 1 January 2025Co-organizer of CROP Innovation & Business (CropIB) 2026 conference alongside CEPLAS and Wageningen University & Research.
• IventusmajorGTM or Marketing Partner · 1 January 2025Conference organizer for CROP Innovation & Business (CropIB) 2026, organized by Iventus in collaboration with KeyGene, VIB, CEPLAS, and WUR.
• Wageningen University & ResearchcoreStrategic or Co-development Partner · 1 January 2024Major research collaborator supporting Yelloway initiative and multiple joint research projects. KeyGene's About page states location in Wageningen, indicating deep ties. Joint research includes hormone-free plant regeneration (published in Plant Cell 2025) and apomixis discovery (Nature Genetics 2022).
• Takara BiomajorTechnology or Integration · 1 January 2024Collaboration on single-nucleus RNA sequencing in pollen. Combined Takara Bio's transcriptomics technology with KeyGene's nuclei isolation expertise and pollen-specific gene expression knowledge.
• Phenome NetworksmajorTechnology or Integration · 1 January 2023Integration of KeyGene's breeding optimizer algorithm into PhenomeOne software package as PhenoGene module, making the tool available to thousands of breeders worldwide on SaaS basis.
• University of MilanmajorStrategic or Co-development Partner · 1 January 2021Collaboration on Georgian grapevine 'Mgaloblishvili' genome sequencing and characterization. Won KeyGene DNA-Day contest 2021, leading to genome publication in Horticulture Research (2025).
• University of California DavismajorStrategic or Co-development Partner · 1 January 2021Collaboration on Georgian grapevine 'Mgaloblishvili' genome sequencing with University of Milan and KeyGene.
• Leibniz Institute of Plant BiochemistrymajorStrategic or Co-development Partner · 1 January 2018Part of EU-financed CHIC research project. Joint research on genome editing of chicory for accumulation of costunolide (anti-cancer compound), published in Frontiers in Plant Science 2022.
• MusaRadixcoreStrategic or Co-development Partner · 1 January 2017Partner in Yelloway initiative - joint venture with Chiquita and MusaRadix, supported by Wageningen University & Research, aiming to develop banana varieties resistant to TR4 and Black Sigatoka diseases.
• ChiquitacoreStrategic or Co-development Partner · 1 January 2017Partner in Yelloway initiative - joint venture with MusaRadix and KeyGene, supported by Wageningen University & Research, aiming to develop banana varieties resistant to TR4 and Black Sigatoka diseases. Completed Yelloway banana pan-genome in February 2026.
• Bioseed (DCM Shriram)majorStrategic or Co-development Partner · 1 January 2017Joint development of hybrid rice lines combining higher yield with good cooking quality for Indian rice farmers. Signing ceremony witnessed by Dutch Prime Minister Mark Rutte in 2023.
• Ball Horticultural CompanymajorStrategic or Co-development Partner · 1 January 2011Supported accelerated breeding of impatiens resistant to downy mildew. Joint genome sequencing of Impatiens walleriana (2018). Ball Horticultural Company is a major customer and research collaborator.
• Enza ZadencoreStrategic or Co-development Partner · 1 January 1989Strategic shareholder and long-term R&D partner. Enza Zaden is one of four strategic shareholders that fund KeyGene's research programs. Ranked #24 in Netherlands' 2025 R&D Top 50.
• Rijk ZwaancoreStrategic or Co-development Partner · 1 January 1989Strategic shareholder and long-term R&D partner. Rijk Zwaan is one of four strategic shareholders that fund KeyGene's research programs. Ranked #12 in Netherlands' 2025 R&D Top 50.
• Limagrain Vegetable Seeds (Vilmorin & Cie)coreStrategic or Co-development Partner · 1 January 1989Strategic shareholder and long-term R&D partner. Vilmorin & Cie represents Limagrain's vegetable seed operations as one of four strategic shareholders funding KeyGene's research.
• TakiicoreStrategic or Co-development Partner · 1 January 1989Strategic shareholder and long-term R&D partner. Takii is one of four strategic shareholders funding KeyGene's research programs. Also collaborated on apomixis research published in Nature Genetics 2022.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• KWS SAAT: KWS is one of the world's leading plant breeding companies for sugar beet, corn, cereals, and vegetables, with substantial R&D in genomics and trait development. Comparable as a customer-archetype for KeyGene's breeding technology services and a fellow European plant-breeding major.
• Corteva Agriscience: Corteva is a global seed and crop protection company with a major R&D investment in gene editing and predictive breeding. Competes with KeyGene-adjacent capabilities but at vastly greater scale and with proprietary germplasm, representing the incumbent landscape in advanced breeding.
• Syngenta Group: Syngenta is a global agricultural technology company with extensive seed and crop protection businesses and significant investment in crop genomics and breeding. Represents a broad incumbent counterpoint to KeyGene's specialized research and platform licensing model.
• Bayer Crop Science: Bayer Crop Science operates one of the largest agricultural R&D programs globally, with extensive breeding and trait development in row crops and vegetables. KeyGene is a licensee and partner of Bayer for some technologies, and Bayer represents the large-incumbent counterpoint to KeyGene's specialized platform model.

Direct peers

• Benson Hill: Benson Hill applies genomics, AI, and predictive breeding to develop improved crop varieties, particularly soybeans. Comparable to KeyGene's crop improvement platform combining genomics, data science, and proprietary breeding tools for partner breeders.
• Cibus: Cibus develops gene-edited crop traits using its Rapid Trait Development System, focusing on oilseed crops, rice, and wheat. Comparable to KeyGene as a technology-platform provider of crop improvement traits to seed companies, with similar licensing and partnership GTM motions.
• Inari Agriculture: Inari is a SEEDesign company combining AI, multiplex gene editing, and computational biology to develop proprietary seeds for corn, soybean, and wheat. Highly comparable to KeyGene's AI-driven Systems Biology platform and trait discovery focus for major field and vegetable crops.
• Tropic Biosciences: Tropic Biosciences is a UK-based AgBiotech company using gene editing for tropical crops including banana, coffee, and rice. Directly comparable to KeyGene's banana (Yelloway/TR4) and rice (Bioseed) programs and its overall gene-editing R&D services model.
• Pairwise: Pairwise is a US-based AgBiotech company using CRISPR and base editing for crop improvement, directly comparable to KeyGene's gene editing and trait development work in fruits, vegetables, and row crops. Both target similar seed-industry customers with platform-based breeding innovation.

Emerging players

• Hudson River Biotechnology: Hudson River Biotechnology is a Netherlands-based AgBiotech applying CRISPR and nanoparticle delivery for plant trait editing. Comparable as a Dutch peer in crop biotech, though smaller and earlier stage than KeyGene with narrower crop focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCNf-5ua_CzRgTnB0L7a0kZw
• Facebookfacebook.com/keygenewageningen
• LinkedInlinkedin.com/company/keygene
• Xx.com/keygeneinfo

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Keygene